The Leadership Team at BioPorto Diagnostics is responsible for setting strategic direction and overseeing the company's operations, ensuring compliance with quality and regulatory standards, driving global medical initiatives, and managing financial reporting. They collaborate to enhance the commercialization of innovative diagnostic solutions, including the NGAL Test for acute kidney injury, while fostering growth and development in the global market.
View all